Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting

Breast cancer stem cells (BCSCs), also known as breast cancer initiating cells, are reported to be responsible for the initiation, progression, therapeutic resistance, and relapse of breast cancer. Conventional therapeutic agents mainly kill the bulk of breast tumor cells and fail to eliminate BCSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Li, Shi, Yonghui, Wu, Junyan, Li, Guocheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914063/
https://www.ncbi.nlm.nih.gov/pubmed/33654398
http://dx.doi.org/10.2147/IJN.S282110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914063/
https://www.ncbi.nlm.nih.gov/pubmed/33654398
http://dx.doi.org/10.2147/IJN.S282110

Ejemplares similares